GlassScriptPhysician profile
Susan L Millard
NPI 1144296344
$1,258.29
in general payments reported to CMS, 2019-2025
24 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $128 · 2021: $223 · 2022: $183 · 2023: $95.34 · 2024: $362 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $306.93 | 2019-2025 | Trikafta |
| Inspire Medical Systems, INC. | $142.66 | 2024 | Inspire |
| Philips North America LLC | $102.65 | 2019-2023 | |
| Aimmune Therapeutics, INC. | $69.65 | 2024-2025 | Zenpep |
| Gilead Sciences, INC. | $67.09 | 2019-2022 | |
| Mylan Specialty L.P. | $64.01 | 2021-2023 | Tobi Podhaler |
| Pharming Healthcare, INC. | $63.40 | 2023-2024 | Ruconest |
| Abbvie INC. | $62.88 | 2019-2021 | |
| Pari Respiratory Equipment, INC. | $44.41 | 2020-2024 | Kitabis Pak |
| Chiesi USA, INC. | $41.00 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $37.36 | 2022 | |
| Ambu INC. | $36.73 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $24.29 | 2021 | |
| Harmony Biosciences LLC | $23.62 | 2024 | |
| Resmed Corp | $22.69 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $22.65 | 2024 | Qsymia |
| Electromed, INC. | $21.53 | 2025 | Smartvest |
| Breas Medical, INC. | $19.69 | 2024 | Vivo 45 Ls |
| Baxter Healthcare | $18.75 | 2024 | Hillrom - Volara System |
| Allergan, INC. | $17.71 | 2019 | |
| Genentech USA, INC. | $17.37 | 2022 | |
| Vapotherm INC | $15.91 | 2021 | |
| Genzyme Corporation | $15.31 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Millard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.